Think of the biggest medical breakthroughs of the modern era. Anything you can name, from the end of smallpox to the recent development of COVID-19 vaccines, owes its existence to clinical research. Clinical research uncovers new or improved treatments for both rare and common conditions, and clinical trials confirm their efficacy and safety in humans.…
Shots: Scott gave a brief about the MedVector and shared his personal experience from his treatment of arthritis by participating in the clinical trial He also elaborated on how MedVector clarified the misunderstanding on FDA’s guidance on DCTs by the clinical research industry at the 41st Annual J.P. Morgan Health Care Conference 2023 The interview…
Play Scott Stout has been recognized as one of the top healthcare innovators of 2021. While working as a professional investor in high-finance, Scott identified a large gap in the clinical trial marketplace and seized the opportunity to build a team of healthcare, high tech, and venture capitalists to turn his concept of expanding clinical…
Patient recruitment remains the leading cause of delay for getting new medical products to market. These delays increase clinical trial costs and can cost Sponsors millions per day in drug-patent protection loss. So how do we, as an industry, combat this? One solution is through “patient-centricity,” which is defined as, “Putting the patient first, in…
In the current clinical trial marketplace, patients must travel to clinical trial sites to access advanced medicine. The problem is, most sites are not near the patients… This creates challenges for doctor/patient awareness, demographic imbalances, and geographic constraints. Further, while treating physicians and specialists believe in clinical trials, they don’t refer their patients to them.…
Company Management Description Lumeon www.lumeon.com Robbie Hughes, Founder & CEO Health systems use Lumeon’s digital health platform to transform their care delivery processes into seamlessly orchestrated, personalized, virtualized care centered on each patient’s needs. With Lumeon, care delivery becomes frictionless, efficient, and effective, ensuring the best standard of safe care is delivered every time. eHealth…
The Huxley Morton Podcast – Series 3, Episode 12. Apple Podcast This week we have several returning guests for a special edition panel show where we discuss ‘What it takes to Change an Industry.’ Our panel of experts include: Scott Stout CEO at Medvector – Finance Expert. Scott’s previous appearance on the show -…
MedVector introduces its Prime-Controltm Technology to provide contract research organizations and pharmaceutical sponsors with access to subjects for new clinical trials. FREMONT, CA: MedVector has begun a nationwide rollout of its Prime-Controltm Technology, which will provide contract research organizations (CROs) and pharmaceutical sponsors with access to numerous patients without the requirement of new clinical trial sites.…
Listen to CEO and Co-Founder, Scott Stout on The Huxley Morton Podcast – Series 2, Episode 8. Apple Podcast This week we hear from Scott Stout Co-founder and CEO of MedVector, a company that is streamlining the Clinical trial Industry. Providing pharmaceutical & Biotech companies, CRO’s and research institutes a global patient network, which enables…
